2018
DOI: 10.1016/j.tiv.2018.06.012
|View full text |Cite
|
Sign up to set email alerts
|

A feasibility study of the toxic responses of human induced pluripotent stem cell-derived hepatocytes to phytochemicals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…To improve the performance of the HLC model, the authors suggested to culture cells in a 3D rather than the current 2D monolayer, because the 3D model has been shown to improve the performance of PHH[68]. In 2018, Smutný et al[69] used HLCs to study the toxicity of phytochemicals saikosaponin D, triptolide, deoxycalyciphylline B and monocrotaline known to cause DILI, in comparison with hepatoblastoma-derived HepG2 cells and long-term culture of primary human hepatocytes (LTHHs). In order to compare the cytotoxic effects of the tested phytochemicals, the authors analyzed hepatocyte key markers in the HLCs compared to the HepG2 and LTHHs controls.…”
Section: Gastrointestinal Toxicitymentioning
confidence: 99%
“…To improve the performance of the HLC model, the authors suggested to culture cells in a 3D rather than the current 2D monolayer, because the 3D model has been shown to improve the performance of PHH[68]. In 2018, Smutný et al[69] used HLCs to study the toxicity of phytochemicals saikosaponin D, triptolide, deoxycalyciphylline B and monocrotaline known to cause DILI, in comparison with hepatoblastoma-derived HepG2 cells and long-term culture of primary human hepatocytes (LTHHs). In order to compare the cytotoxic effects of the tested phytochemicals, the authors analyzed hepatocyte key markers in the HLCs compared to the HepG2 and LTHHs controls.…”
Section: Gastrointestinal Toxicitymentioning
confidence: 99%
“…Despite the clinical benefits of SSs in a variety of disease models, clinical use of Radix bupleuri products produce several severe adverse effects, including pain, allergy, low blood pressure, dizziness, convulsion as well as limb twitching (Ikegami et al, 2006), untoward effects that have precipitated a black box warning on injectable formulations of Radix bupleuri by China Food and Drug Administration on May 29 th , 2018 (http://cnda.cfda.gov.cn/WS04/CL2050/228214.html). Results from toxicological studies demonstrate that SSd induces cells death in human LO2 hepatocytes and pluripotent stem cell-derived hepatocytes, possibly through disrupting platelet-derived growth factor-β receptor/p38 and activating Fas death receptor within the concentration range capable of producing therapeutic effects (Chen et al, 2013; Li et al, 2017c; Smutny et al, 2018; Zhang et al, 2016). Most recently, SSd has also been demonstrated to produce neurotoxicity.…”
Section: Introductionmentioning
confidence: 99%